Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Dominari Holdings Files $2 Billion Shelf to Support Strategic Expansion (PR Newswire) +++ DOMINARI Aktie +3,23%

PHIBRO Aktie

 >PHIBRO Aktienkurs 
32.6 EUR    +17.3%    (Tradegate)
Ask: 33.2 EUR / 100 Stück
Bid: 31.8 EUR / 90 Stück
Tagesumsatz: 45 Stück
Realtime Kurs von 8 bis 22 Uhr!
PHIBRO Aktie über LYNX handeln
>PHIBRO Performance
1 Woche: +3,7%
1 Monat: +9,1%
3 Monate: +28,2%
6 Monate: +30,0%
1 Jahr: +63,9%
laufendes Jahr: +37,5%
>PHIBRO Aktie
Name:  PHIBRO ANIMAL HEALTH A
Land:  USA
Sektor:  Konsumgueter / Gastronomie
ISIN/ Wkn:  US71742Q1067 / A1WZ6P
Symbol/ Ticker:  PB8 (Frankfurt) / PAHC (NASDAQ)
Kürzel:  FRA:PB8, ETR:PB8, PB8:GR, NASDAQ:PAHC
Index:  -
Webseite:  -
Profil:  Phibro Animal Health Corporation is a pharmaceutic..
>Volltext..
Marktkapitalisierung:  1142.34 Mio. EUR
Unternehmenswert:  1792.54 Mio. EUR
Umsatz:  1028.08 Mio. EUR
EBITDA:  142.22 Mio. EUR
Nettogewinn:  27.45 Mio. EUR
Gewinn je Aktie:  0.68 EUR
Schulden:  664.87 Mio. EUR
Liquide Mittel:  52.11 Mio. EUR
Operativer Cashflow:  75.36 Mio. EUR
Bargeldquote:  0.26
Umsatzwachstum:  18.81%
Gewinnwachstum:  140.91%
Dividende je Aktie:  0.44 EUR
Dividendenrendite:  1.47%
Dividendenschätzung:  1.47%
Div. Historie:  04.06.25 - 0.105372€
05.03.25 - 0.110532€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  PHIBRO
Letzte Datenerhebung:  28.08.25
>PHIBRO Kennzahlen
Aktien/ Unternehmen:
Aktien: 20.37 Mio. St.
Frei handelbar: 99.26%
Rückkaufquote: -
Mitarbeiter: 1940
Umsatz/Mitarb.: 0.45 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: -19.68%
Bewertung:
KGV: 38.48
KGV lG: 16.11
KUV: 1.08
KBV: 4.58
PEG-Ratio: 0.29
EV/EBITDA: 12.6
Rentabilität:
Bruttomarge: 32.51%
Gewinnmarge: 2.67%
Operative Marge: 10.27%
Managementeffizenz:
Gesamtkaprendite: 2.77%
Eigenkaprendite: 11.86%
>PHIBRO Peer Group

Es sind 275 Aktien bekannt.
 
28.08.25 - 08:30
Phibro Animal Health Stock Surges 18% After-Hours On Strong Q4 Earnings Beat (Benzinga)
 
Phibro shares soared nearly 18% after strong Q4 results beat estimates, driven by growth from the Zoetis MFA acquisition and solid full-year performance. Latest Ratings for PAHC DateFirmActionFromTo Jan 2022BarclaysUpgradesUnderweightEqual-Weight Nov 2021Morgan StanleyInitiates Coverage OnEqual-Weight Jul 2021BarclaysDowngradesEqual-WeightUnderweight View More Analyst Ratings for PAHC View the Latest Analyst Ratings read more...
28.08.25 - 01:45
Phibro (PAHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
 
The headline numbers for Phibro (PAHC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....
28.08.25 - 01:45
Phibro Animal Health (PAHC) Tops Q4 Earnings and Revenue Estimates (Zacks)
 
Phibro (PAHC) delivered earnings and revenue surprises of +9.62% and +4.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...
27.08.25 - 23:48
Phibro Animal Health Q4 Revenue Up 39% (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
27.08.25 - 23:06
Phibro Animal Non-GAAP EPS of $0.57 beats by $0.05, revenue of $378.7M beats by $16.46M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
27.08.25 - 23:00
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance (Business Wire)
 
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2025 and provided its financial guidance for the year ending June 30, 2026. Highlights for the three months ended June 30, 2025 (compared to the three months ended June 30, 2024) Net sales of $378.7 million, an increase of $105.5 million, or 39% Net income of $17.2 million, an increase of $16.5 million Diluted earnings per share of $0.42, an increase of $0.40 Adjusted EBITDA of $50.0 million, an increase of $16.5 million, or 49% Adjusted net income of $23.2 million, an increase of $6.6 million, or 39% Adjusted diluted EPS of $0.57, an increase of $0.16, or 39% Highlights for the year ended June 30, 2025 (compared to the year ended June 30, 2024) Net sales of $1,296.2 million, an increase of $278.5 million, or 27% Net income of $48.3 million, an increase of $45.8 million Diluted earnings per share of $1.19...
22.08.25 - 16:45
Insights Into Phibro (PAHC) Q4: Wall Street Projections for Key Metrics (Zacks)
 
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Phibro (PAHC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025....
20.08.25 - 22:03
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2025 Results (Business Wire)
 
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its fourth quarter and fiscal year 2025 financial results on Wednesday, August 27, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 28, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the webcast recording, visit https://investors.pahc.com. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, ...
20.08.25 - 16:45
Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run? (Zacks)
 
Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues....
18.08.25 - 20:30
Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
 
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials....
01.08.25 - 20:30
3 Reasons Growth Investors Will Love Phibro (PAHC) (Zacks)
 
Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market....
29.07.25 - 22:48
Phibro Animal declares $0.12 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.07.25 - 22:15
Phibro Animal Health Corporation Declares Quarterly Dividend (Business Wire)
 
TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 24, 2025, to stockholders of record at the close of business on September 3, 2025. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. For further information, please visit www.pahc.com. Contacts Phibro Animal Health Corporation Glenn David Chief Financial Officer +1-201-329-7300 Or investor.relations@pahc.com...
16.07.25 - 20:30
3 Reasons Why Growth Investors Shouldn′t Overlook Phibro (PAHC) (Zacks)
 
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials....
11.07.25 - 17:30
Here′s Why Phibro Animal Health (PAHC) is a Strong Momentum Stock (Zacks)
 
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....
10.07.25 - 19:45
Phibro Animal Health (PAHC) is a Great Momentum Stock: Should You Buy? (Zacks)
 
Does Phibro Animal Health (PAHC) have what it takes to be a top stock pick for momentum investors? Let's find out....
07.07.25 - 19:09
Phibro Animal Health soars after J.P. Morgan upgrades on solid execution, higher margins (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
02.07.25 - 16:45
Phibro Animal Health Corporation (PAHC) Hit a 52 Week High, Can the Run Continue? (Zacks)
 
Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues....
01.07.25 - 16:00
Phibro Animal Health Stock Up 52.8% in a Year: What′s Driving the Rise? (Zacks)
 
PAHC stock is under investors' radar due to its booming animal health sales, new product lines and rising vaccine demand....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Die Affen sind unsere Verwandten, und wir sollten stolz darauf sein. - Dr. Antal Festetics
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!